Vigil Neuroscience (NASDAQ:VIGL) Cut to “Underweight” at Morgan Stanley

Morgan Stanley lowered shares of Vigil Neuroscience (NASDAQ:VIGL – Free Report) from an equal weight rating to an underweight rating in a research report sent to investors on Tuesday, Marketbeat reports. Morgan Stanley currently has $4.00 price objective on the stock, down from their previous price objective of $13.00. A number of other research firms […]

Leave a Reply

Your email address will not be published.

Previous post Astec Industries (NASDAQ:ASTE) Price Target Raised to $42.00 at Stifel Nicolaus
Next post Wave Life Sciences (NASDAQ:WVE) Upgraded to Outperform at Leerink Partnrs